Mereo Biopharma Group Plc ADR (NASDAQ:MREO) has a beta value of 0.80 and has seen 1.58 million shares traded in the last trading session. The company, currently valued at $427.18M, closed the last trade at $3.05 per share which meant it gained $0.29 on the day or 10.51% during that session. The MREO stock price is -42.95% off its 52-week high price of $4.36 and 69.84% above the 52-week low of $0.92. The 3-month trading volume is 1.26 million shares.
Mereo Biopharma Group Plc ADR (NASDAQ:MREO) trade information
Sporting 10.51% in the green in last session, the stock has traded in the green over the last five days, when the MREO stock price touched $3.05 or saw a rise of 1.29%. Year-to-date, Mereo Biopharma Group Plc ADR shares have moved 32.03%, while the 5-day performance has seen it change 9.71%. Over the past 30 days, the shares of Mereo Biopharma Group Plc ADR (NASDAQ:MREO) have changed -10.56%.
Mereo Biopharma Group Plc ADR (MREO) estimates and forecasts
Figures show that Mereo Biopharma Group Plc ADR shares have outperformed across the wider relevant industry. The company’s shares have gained 68.51% over the past 6 months, with this year growth rate of 115.00%, compared to 12.60% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 41.78% over the past 5 years.
MREO Dividends
Mereo Biopharma Group Plc ADR is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
